Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruifeng Xu

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Allergologia Et Immunopathologia|November 6, 2022
Whole-exome sequencing identified a homozygous novel <i>RAG1</i> mutation in a child with omenn syndromeWendi Wang, Jian Wang, Jingjing Wang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 10, 2026
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical ModelJan Mikelson, Richard Birnie, Grant McCarthy, et al.
Viruses|October 29, 2025
Transcontinental Spread of HPAI H5N1 from South America to Antarctica via Avian VectorsRuifeng Xu, Minhao Gao, Nailou Zhang, et al.
Journal of Medical Economics|March 12, 2024
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in SwedenLewis Ralph, Kate Young, Navneet Upadhyay, et al.
European Urology Oncology|August 15, 2019
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in SwedenTushar Srivastava, Vimalanand S Prabhu, Haojie Li, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|January 29, 2023
[Clinical features and genetic analysis of a child with acute form of Tyrosinemia type I due to a novel variant of FAH gene]Qinghua Zhang, Chuan Zhang, Yupei Wang, et al.
European Journal of Radiology|June 18, 2026
Deep learning reconstruction for chest MRI: image quality and diagnostic agreement with CTJiuming Jiang, Mengwen Liu, Ruifeng Xu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 9, 2011
Body mass index, recreational physical activity and female urinary incontinence in Gansu, ChinaJie Qiu, Ling Lv, Xiaojuan Lin, et al.
Journal of Medical Economics|January 31, 2024
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UKGrant McCarthy, Kate Young, Matthew Madin-Warburton, et al.
European Urology Oncology|August 15, 2019
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based TherapyKarl Patterson, Vimalanand Prabhu, Ruifeng Xu, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Allergologia Et Immunopathologia|November 6, 2022
Whole-exome sequencing identified a homozygous novel <i>RAG1</i> mutation in a child with omenn syndromeWendi Wang, Jian Wang, Jingjing Wang, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 10, 2026
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical ModelJan Mikelson, Richard Birnie, Grant McCarthy, et al.
Viruses|October 29, 2025
Transcontinental Spread of HPAI H5N1 from South America to Antarctica via Avian VectorsRuifeng Xu, Minhao Gao, Nailou Zhang, et al.
Journal of Medical Economics|March 12, 2024
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in SwedenLewis Ralph, Kate Young, Navneet Upadhyay, et al.
European Urology Oncology|August 15, 2019
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in SwedenTushar Srivastava, Vimalanand S Prabhu, Haojie Li, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|January 29, 2023
[Clinical features and genetic analysis of a child with acute form of Tyrosinemia type I due to a novel variant of FAH gene]Qinghua Zhang, Chuan Zhang, Yupei Wang, et al.
European Journal of Radiology|June 18, 2026
Deep learning reconstruction for chest MRI: image quality and diagnostic agreement with CTJiuming Jiang, Mengwen Liu, Ruifeng Xu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 9, 2011
Body mass index, recreational physical activity and female urinary incontinence in Gansu, ChinaJie Qiu, Ling Lv, Xiaojuan Lin, et al.
Journal of Medical Economics|January 31, 2024
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UKGrant McCarthy, Kate Young, Matthew Madin-Warburton, et al.
European Urology Oncology|August 15, 2019
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based TherapyKarl Patterson, Vimalanand Prabhu, Ruifeng Xu, et al.
Pageof 9